Bart Lagerwaard has a background in Molecular Nutrition and a PhD in Human Physiology. His work focuses on clinical trial innovation, particularly in the areas of technology, artificial intelligence, and patient-centric approaches.
He has extensive experience in conducting European clinical trials and exploring the impact of novel trial innovations such as decentralized trial elements and artificial intelligence. Bart frequently operates in large public-private consortia, collaborating with pharmaceutical companies, contract research organizations, patient organizations, and regulatory bodies. Through these partnerships, he helps strengthen the clinical trial ecosystem both within and beyond the UMC Utrecht. Additionally, Bart coordinates the professional and post-graduate course in Clinical Epidemiology.